San Francisco, 21
September 2018: The global small animal imaging (In-Vivo) market size is expected to reach 2.7 billion by 2022, according
to a new report by Grand View Research, Inc., progressing at a CAGR of 9.0%
during the forecast period. Rising number of medical conditions requiring
precise research for development of treatment options is anticipated to stoke
the demand for small animal imaging over the forecast period.
Importance of these
devices in applications such as defining mechanism of action, drug receptor
targeting, and epigenetic research studies are projected to provide substantial
growth for the market. Some of the major drivers of small animal imaging
(in-vivo) market are technical innovations such as high-resolution MRI with
other modalities, growing number of research and pharmaceutical organizations,
increasing investments of CROs in pre-clinical studies, and rising adoption of
multi-functional pre-clinical imaging.
Access Research Report
of Small Animal Imaging
(In-vivo) Market @ www.grandviewresearch.com/industry-analysis/small-animal-imaging-in-vivo-market
Further key findings from the report suggest:
· Optical imaging was the largest segment in
2014 owing to rapid and easy operations and relatively cost-effective in
comparison to other devices
· Micro-MRI technology is anticipated to be
the fastest growing segment over the forecast period due varied applications
during anatomical and functional analysis in developing mouse embryos and
neonates
· In 2014, bio-distribution and monitoring
the treatment response dominated the market in terms of revenue
· The cancer cell detection segment is
expected to show substantial growth due to the increasing prevalence of cancer
and rising government initiatives for cancer diagnostics research
· North America was the largest region in
terms of revenue in 2016. Vast pre-clinical research, increasing demand for
rapid and advanced methods, established healthcare infrastructure, and
favorable platform for R&D pertaining to technological advancements are the
key factors driving the regional market
· Europe was the second largest region in
2014, due to a large number of clinical research and pharmaceutical
organizations and diagnostic device manufacturers
· Asia Pacific is projected to be the fastest
growing region over the forecast period owing to increasing clinical research
activities, rising base of target population, and emerging economies
· Some of the key players are Promega
Corporation, Inc.; Miltenyi Biotec GmbH; Life Technologies Corporation;
FujiFilm Holding Corporation; Siemens AG; Thermo Fisher Scientific; Bruker
Corporation; PerkinElmer Inc.; and Aspect Imaging Ltd.
Browse more reports of this category by Grand View
Research at: www.grandviewresearch.com/industry/healthcare
Grand View Research has
segmented the global small animal imaging (in vivo) market on the basis of
technology, application, and region:
Small Animal Imaging (In-vivo) Technology Outlook
(Revenue, USD Million, 2012 - 2022)
·
Micro-magnetic resonance imaging
·
Optical imaging
·
Nuclear imaging
·
Other imaging modalities
Small Animal Imaging (In-vivo) Application Outlook
(Revenue, USD Million, 2012 - 2022)
·
Monitoring treatment response
·
Bio-distribution
·
Cancer cell detection
·
Biomarkers
·
Longitudinal studies
·
Epigenetics
Small Animal Imaging (In-vivo) Regional Outlook
(Revenue, USD Million, 2012 - 2022)
·
North America
·
Europe
·
Asia Pacific
·
RoW
Access Press Release of
Small Animal Imaging (In-vivo) Market@ www.grandviewresearch.com/press-release/global-small-animal-imaging-in-vivo-market
About
Grand View Research
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco.
The company provides syndicated research reports, customized research reports, and consulting services. To help
clients make informed business decisions, we offer market intelligence studies ensuring relevant and
fact-based research across a range of industries, from technology to chemicals,
materials and healthcare.
No comments:
Post a Comment